Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · Real-Time Price · USD
20.44
+0.18 (0.89%)
Nov 13, 2026, 4:00 PM EST - Market closed
Sabra Health Care REIT Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, Sabra Health Care REIT stock has a consensus rating of "Buy" and an average price target of $22.71. The average 1-year stock price forecast is 11.11% higher than the current stock price, while the lowest is $19 (-7.05%) and the highest is $25 (+22.31%).
Price Target: $22.71 (+11.11%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Sabra Health Care REIT stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 9 | 9 | 10 | 10 | 10 | 10 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 16 | 16 | 16 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Reiterates $20 → $22 | Hold | Reiterates | $20 → $22 | +7.63% | Nov 11, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $25 | Buy | Reiterates | $25 | +22.31% | Nov 9, 2026 |
| Scotiabank | Scotiabank | Hold Maintains $20 | Hold | Maintains | $20 | -2.15% | Nov 3, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $23 → $21 | Buy | Maintains | $23 → $21 | +2.74% | Nov 3, 2026 |
| Barclays | Barclays | Hold Maintains $23 → $21 | Hold | Maintains | $23 → $21 | +2.74% | Oct 13, 2026 |
Financial Forecast
Revenue This Year
865.40M
from 775.76M
Increased by 11.55%
Revenue Next Year
997.90M
from 865.40M
Increased by 15.31%
EPS This Year
0.67
EPS Next Year
0.67
from 0.67
EPS based on non-GAAP adjusted numbers.